Showing results (171-180 of 405) with videos related to
Sort By:
Pageof 41
Investigational New Drugs|January 1, 1995
Pharmacology, relative bioavailability, and toxicity of three different oral cyclophosphamide preparations in a randomized, cross-over studyD J Stewart, L R Morgan, S Verma, et al.American Journal of Clinical Oncology|April 1, 1993
Phase II multicenter study of epirubicin for hormone-resistant prostatic cancer with measurable soft tissue diseaseI F Tannock, T J Erwin, D J Stewart, et al.Journal of Cardiovascular Pharmacology|January 1, 1995
Plasma endothelin-1 levels in human lung transplant recipientsH Shennib, C Serrick, D Saleh, et al.American Journal of Clinical Oncology|December 1, 1989
Phase I study of weekly intravenous administration of menogaril to adults with solid tumorsD J Stewart, J A Maroun, S Verma, et al.Journal of Neuro-Oncology|February 1, 1993
Phase II study of tiazofurin in gliomas in adults. A National Cancer Institute of Canada studyD J Stewart, E Eisenhauer, D R Macdonald, et al.Muscle & Nerve|October 1, 1996
Lambert-Eaton myasthenic syndrome presenting with severe respiratory failureM W Nicolle, D J Stewart, H Remtulla, et al.Transplantation|April 15, 1995
Alterations in bronchoalveolar lavage and plasma endothelin-1 levels early after lung transplantationH Shennib, C Serrick, D Saleh, et al.Breast Cancer Research and Treatment|January 1, 1985
Mitomycin-C plus metronidazole in advanced carcinoma of the breastD J Stewart, J A Maroun, B Lefebvre, et al.Toxicology Letters|March 5, 1998
HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomesT Inaba, N E Fischer, D S Riddick, et al.Nature Biotechnology|March 6, 1998
Design, synthesis, and application of a protein A mimeticR Li, V Dowd, D J Stewart, et al.Pageof 41